首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備

市場調查報告書

商品編碼

1578288

全球自動注射器市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢和預測

Global Autoinjectors Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年09月01日 | 出版商:

Value Market Research | 英文 128 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球自動注射器市場需求預計將從 2023 年的 17.8 億美元達到 2032 年近 71.6 億美元的市場規模，2024-2032 年研究期間複合年成長率為 16.74%。

自動注射器是一種醫療設備，可以在較少焦慮和壓力的情況下自行注射特定藥物。使用通常是一次性的彈簧加載注射器很容易。它可用於肌肉內和皮下注射，通常注射到臀部或大腿。它有不同的形狀和尺寸以及多種功能，例如可調節注射深度、藥物檢查視窗、可伸縮針頭、自動語音指令和顏色編碼的用過指示器。該裝置經常被軍事人員用於急救，以保護自己免受化學戰劑的侵害。

市場動態

全球人口自我給藥治療的廣泛增加將成為該市場成長的關鍵驅動力。減少就診次數和健康保險機構費用的目標將進一步推動自動注射器市場在慢性病患者中的發展。這個市場的主要吸引力部分是使用注射自我給藥治療類風濕性關節炎、多發性硬化症和糖尿病患者的日益成長的趨勢。自動注射器的各種優點可以為製藥和生物製藥行業節省大量時間和金錢。該市場面臨的挑戰與用於製造自動注射器中使用的彈簧和其他精密金屬部件的材料有關

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球自動注射器市場的每個細分市場進行了包容性評估。自動注射器產業的成長和趨勢為本研究提供了整體方法。

市場區隔

自動注射器市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人口統計數據以及即將到來的機會。

按類型

一次性的
可重複使用的

依技術

手持式
穿戴式

依給藥途徑

皮下
肌肉注射

按指示

多發性硬化症
類風濕關節炎
糖尿病
過敏反應
其他（腫瘤學、免疫學等）

按最終用戶

家庭護理設置
醫院和診所

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲自動注射器市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。自動注射器市場的主要參與者包括 Ypsomed Holding AG、諾華 AG、BD、Medmix Healthcare、禮來公司、賽諾菲、Mylan NV、Amgen Inc.、SHL Medical AG、Recipharm AB。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

簡介 - 市場動態
市場促進因素
市場限制
機會
產業動態
波特五力分析
市場吸引力分析
- 按類型分類的市場吸引力分析
- 按技術分類的市場吸引力分析
- 按給藥途徑進行的市場吸引力分析
- 按指標進行的市場吸引力分析
- 最終用戶的市場吸引力分析
- 市場吸引力分析：按地區

第 4 章：價值鏈分析

價值鏈分析
原料分析
- 原料清單
- 原料廠商清單
- 主要原物料價格走勢
潛在買家名單
行銷管道
- 直效行銷
- 間接行銷
- 行銷通路發展趨勢

第 5 章：全球自動注射器市場分析：按類型

按類型概述
按類型分析歷史和預測數據
一次性的
可重複使用的

第 6 章：全球自動注射器市場分析：按技術分類

依技術概述
按技術進行歷史和預測數據分析
手持式
穿戴式

第 7 章：全球自動注射器市場分析：按管理途徑

依給藥途徑概述
按給藥途徑進行歷史和預測資料分析
皮下
肌肉注射

第 8 章：全球自動注射器市場分析：按跡象分類

按指示概述
按指示進行歷史和預測資料分析
多發性硬化症
類風濕關節炎
糖尿病
過敏反應
其他（腫瘤學、免疫學等）

第 9 章：全球自動注射器市場分析：依最終使用者分類

最終用戶概述
最終用戶的歷史和預測數據分析
家庭護理設置
醫院和診所

第 10 章：全球自動注射器市場分析：依地理位置

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 11 章：自動注射器公司的競爭格局

自動注射器市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 12 章：公司簡介

頂級公司市佔率分析
市場集中度
Ypsomed Holding AG

公司概況
公司收入
產品
最新動態

Novartis AG

公司概況
公司收入
產品
最新動態

公司概況
公司收入
產品
最新動態

Medmix Healthcare

公司概況
公司收入
產品
最新動態

Eli Lilly And Company

公司概況
公司收入
產品
最新動態

Sanofi

公司概況
公司收入
產品
最新動態

Mylan NV

公司概況
公司收入
產品
最新動態

Amgen Inc.

公司概況
公司收入
產品
最新動態

SHL Medical AG

公司概況
公司收入
產品
最新動態

Recipharm AB

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR11213513

The global demand for Autoinjectors Market is presumed to reach the market size of nearly USD 7.16 Billion by 2032 from USD 1.78 Billion in 2023 with a CAGR of 16.74% under the study period 2024-2032.

An autoinjector is a medical device that enables the self-administration of a particular drug with less anxiety and stress. It is easy to use a spring-loaded syringe that is generally disposable. It can be used for intramuscular and subcutaneous injection, typically administered into the buttocks or the thigh. It comes in different shapes and sizes along with several features like adjustable injection depth, a drug inspection window, retractable needle, automated voice instruction, and color-coded spent indicator. This device is often used by military personnel for first aid to protect themselves from chemical warfare agents.

MARKET DYNAMICS

The widespread increase in self-administration of drug therapies among the global population will be the key driving force behind this market's growth. The aim to reduce the number of hospital visits and the expenses involved by health insurance agencies will further propel the autoinjectors' market among chronic patients. This market's main attractive segment is the growing trend to treat rheumatoid arthritis, multiple sclerosis, and diabetic patients using injectable self-administration. The various advantages of an autoinjector can save considerable time and money for the pharmaceutical and biopharmaceutical industries. The challenges faced by this market are related to the materials used for the manufacture of springs and other precision metal components used in an autoinjector

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Autoinjectors. The growth and trends of Autoinjectors industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Autoinjectors market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

Disposable
Reusable

By Technology

Handheld
Wearable

By Route of Administration

Subcutaneous
Intramuscular

By Indication

Multiple Sclerosis
Rheumatoid Arthritis
Diabetes
Anaphylaxis
Others (Oncology, Immunology etc.)

By End-user

Homecare Settings
Hospitals & Clinics

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Autoinjectors market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Autoinjectors market include Ypsomed Holding AG, Novartis AG, BD, Medmix Healthcare, Eli Lilly And Company, Sanofi, Mylan N.V., Amgen Inc., SHL Medical AG, Recipharm AB. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. AUTOINJECTORS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Technology
- 3.7.3 Market Attractiveness Analysis By Route of Administration
- 3.7.4 Market Attractiveness Analysis By Indication
- 3.7.5 Market Attractiveness Analysis By End-user
- 3.7.6 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL AUTOINJECTORS MARKET ANALYSIS BY TYPE

5.1. Overview By Type
5.2. Historical and Forecast Data Analysis By Type
5.3. Disposable Historic and Forecast Sales By Regions
5.4. Reusable Historic and Forecast Sales By Regions

6. GLOBAL AUTOINJECTORS MARKET ANALYSIS BY TECHNOLOGY

6.1. Overview By Technology
6.2. Historical and Forecast Data Analysis By Technology
6.3. Handheld Historic and Forecast Sales By Regions
6.4. Wearable Historic and Forecast Sales By Regions

7. GLOBAL AUTOINJECTORS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

7.1. Overview By Route of Administration
7.2. Historical and Forecast Data Analysis By Route of Administration
7.3. Subcutaneous Historic and Forecast Sales By Regions
7.4. Intramuscular Historic and Forecast Sales By Regions

8. GLOBAL AUTOINJECTORS MARKET ANALYSIS BY INDICATION

8.1. Overview By Indication
8.2. Historical and Forecast Data Analysis By Indication
8.3. Multiple Sclerosis Historic and Forecast Sales By Regions
8.4. Rheumatoid Arthritis Historic and Forecast Sales By Regions
8.5. Diabetes Historic and Forecast Sales By Regions
8.6. Anaphylaxis Historic and Forecast Sales By Regions
8.7. Others (Oncology, Immunology etc.) Historic and Forecast Sales By Regions

9. GLOBAL AUTOINJECTORS MARKET ANALYSIS BY END-USER

9.1. Overview By End-user
9.2. Historical and Forecast Data Analysis By End-user
9.3. Homecare Settings Historic and Forecast Sales By Regions
9.4. Hospitals & Clinics Historic and Forecast Sales By Regions

10. GLOBAL AUTOINJECTORS MARKET ANALYSIS BY GEOGRAPHY

10.1. Regional Outlook
10.2. Introduction
10.3. North America Sales Analysis
- 10.3.1 Overview, Historic and Forecast Data Sales Analysis
- 10.3.2 North America By Segment Sales Analysis
- 10.3.3 North America By Country Sales Analysis
- 10.3.4 United States Sales Analysis
- 10.3.5 Canada Sales Analysis
- 10.3.6 Mexico Sales Analysis
10.4. Europe Sales Analysis
- 10.4.1 Overview, Historic and Forecast Data Sales Analysis
- 10.4.2 Europe By Segment Sales Analysis
- 10.4.3 Europe By Country Sales Analysis
- 10.4.4 United Kingdom Sales Analysis
- 10.4.5 France Sales Analysis
- 10.4.6 Germany Sales Analysis
- 10.4.7 Italy Sales Analysis
- 10.4.8 Russia Sales Analysis
- 10.4.9 Rest Of Europe Sales Analysis
10.5. Asia Pacific Sales Analysis
- 10.5.1 Overview, Historic and Forecast Data Sales Analysis
- 10.5.2 Asia Pacific By Segment Sales Analysis
- 10.5.3 Asia Pacific By Country Sales Analysis
- 10.5.4 China Sales Analysis
- 10.5.5 India Sales Analysis
- 10.5.6 Japan Sales Analysis
- 10.5.7 South Korea Sales Analysis
- 10.5.8 Australia Sales Analysis
- 10.5.9 South East Asia Sales Analysis
- 10.5.10 Rest Of Asia Pacific Sales Analysis
10.6. Latin America Sales Analysis
- 10.6.1 Overview, Historic and Forecast Data Sales Analysis
- 10.6.2 Latin America By Segment Sales Analysis
- 10.6.3 Latin America By Country Sales Analysis
- 10.6.4 Brazil Sales Analysis
- 10.6.5 Argentina Sales Analysis
- 10.6.6 Peru Sales Analysis
- 10.6.7 Chile Sales Analysis
- 10.6.8 Rest of Latin America Sales Analysis
10.7. Middle East & Africa Sales Analysis
- 10.7.1 Overview, Historic and Forecast Data Sales Analysis
- 10.7.2 Middle East & Africa By Segment Sales Analysis
- 10.7.3 Middle East & Africa By Country Sales Analysis
- 10.7.4 Saudi Arabia Sales Analysis
- 10.7.5 UAE Sales Analysis
- 10.7.6 Israel Sales Analysis
- 10.7.7 South Africa Sales Analysis
- 10.7.8 Rest Of Middle East And Africa Sales Analysis

11. COMPETITIVE LANDSCAPE OF THE AUTOINJECTORS COMPANIES

11.1. Autoinjectors Market Competition
11.2. Partnership/Collaboration/Agreement
11.3. Merger And Acquisitions
11.4. New Product Launch
11.5. Other Developments

12. COMPANY PROFILES OF AUTOINJECTORS INDUSTRY

12.1. Top Companies Market Share Analysis
12.2. Market Concentration Rate
12.3. Ypsomed Holding AG
- 12.3.1 Company Overview
- 12.3.2 Company Revenue
- 12.3.3 Products
- 12.3.4 Recent Developments
12.4. Novartis AG
- 12.4.1 Company Overview
- 12.4.2 Company Revenue
- 12.4.3 Products
- 12.4.4 Recent Developments
12.5. BD
- 12.5.1 Company Overview
- 12.5.2 Company Revenue
- 12.5.3 Products
- 12.5.4 Recent Developments
12.6. Medmix Healthcare
- 12.6.1 Company Overview
- 12.6.2 Company Revenue
- 12.6.3 Products
- 12.6.4 Recent Developments
12.7. Eli Lilly And Company
- 12.7.1 Company Overview
- 12.7.2 Company Revenue
- 12.7.3 Products
- 12.7.4 Recent Developments
12.8. Sanofi
- 12.8.1 Company Overview
- 12.8.2 Company Revenue
- 12.8.3 Products
- 12.8.4 Recent Developments
12.9. Mylan N.V.
- 12.9.1 Company Overview
- 12.9.2 Company Revenue
- 12.9.3 Products
- 12.9.4 Recent Developments
12.10. Amgen Inc.
- 12.10.1 Company Overview
- 12.10.2 Company Revenue
- 12.10.3 Products
- 12.10.4 Recent Developments
12.11. SHL Medical AG
- 12.11.1 Company Overview
- 12.11.2 Company Revenue
- 12.11.3 Products
- 12.11.4 Recent Developments
12.12. Recipharm AB
- 12.12.1 Company Overview
- 12.12.2 Company Revenue
- 12.12.3 Products
- 12.12.4 Recent Developments